PCV89 Comparison of Dosing Patterns Among Patients Initiating Statin Therapy in a Managed Care Population (original) (raw)
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention
Johanne Collin
British Journal of Clinical Pharmacology, 2005
View PDFchevron_right
Factors associated with statin selection among privately insured commercial and Medicare patients
LeRoy LeNarz
Current Medical Research and Opinion, 2013
View PDFchevron_right
Statins: effects beyond cholesterol lowering
Garry Shen
Nephrology Dialysis Transplantation, 2001
View PDFchevron_right
Psychologic Disorders and Statin Use: A Propensity Score-Matched Analysis
Mary Jo Pugh
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
View PDFchevron_right
Potential Impact on Cardiovascular Public Health of Over-the-Counter Statin Availability
Shannon Ferrante
The American Journal of Cardiology, 2006
View PDFchevron_right
Comparative evaluation of the effect of statin drugs in Hyperlipidaemic patients
JAWAHAR FAROOK
2011
View PDFchevron_right
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
John Kjekshus
The Lancet, 2019
View PDFchevron_right
Patient Characteristics and General Practitioners’ Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries
Sanda Kreitmayer Pestic MD, PhD.
Journal of General Internal Medicine, 2019
View PDFchevron_right
Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering
John Kjekshus
The American Journal of Cardiology, 2000
View PDFchevron_right
Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups
ALI RAZA
The American Journal of Cardiology, 2003
View PDFchevron_right
Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
Louise Falzon
Annals of Pharmacotherapy, 2010
View PDFchevron_right
Secondary prevention of heart disease with statins: Authors' reply
Peter Davey
BMJ, 2005
View PDFchevron_right
Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin
Basil S Lewis
JAMA Cardiology, 2017
View PDFchevron_right
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins
Juan Badimon
2000
View PDFchevron_right
Comparison of the Risk of Psychological and Cognitive Disorders Between Persistent and Nonpersistent Statin Users
Mary Jo Pugh
The American Journal of Cardiology, 2014
View PDFchevron_right
An overview of pleiotropic effect of statins in cardiovascular disease
Kumud Upadhyaya
Pharmacy & pharmacology international journal, 2018
View PDFchevron_right
ASCVD risk refinement with NT-proBNP for statin allocation among low- and intermediate risk individuals
Maarten Leening
medRxiv (Cold Spring Harbor Laboratory), 2024
View PDFchevron_right
Severe knee pain related to statin treatment – not to be confused with osteoarthritis of the knee
Stephen Malnick
Case Reports in Internal Medicine, 2015
View PDFchevron_right
Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry
Daniela Palomo De la Sota
Drugs, 2021
View PDFchevron_right
Targeted study to evaluate the cardiovascular risk factor status among patients and efficacy of statins in attaining goal lipid levels in a regional hospital in Sultanate of Oman
Qasim Al Riyami
Saudi Pharmaceutical Journal, 2015
View PDFchevron_right
Statin use, hyperlipidaemia, and the risk of breast cancer
Alec Walker
2002
View PDFchevron_right
Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001–2004
Angelo Marzo
Cancer Causes & Control, 2010
View PDFchevron_right
Statin Therapy and Increased Coronary Heart Disease Risk in Primary Prevention of People with Enhanced Low-Grade Inflammation
Hasan Kaya
Turkiye Klinikleri Cardiovascular Sciences, 2014
View PDFchevron_right
Long-Term Persistence on Statins Following Myocardial Infarction in a Population-Cohort: Age and Gender Perspective
Judy Katzenellenbogen
Heart, Lung and Circulation, 2016
View PDFchevron_right
Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study
ALI RAZA
American Heart Journal, 2004
View PDFchevron_right
Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes
Yook C Chia
Diabetology & Metabolic Syndrome, 2014
View PDFchevron_right
Statins and the kidney: friend or foe?
Jouke Regt
The Lancet Diabetes & Endocrinology, 2015
View PDFchevron_right
Usefulness of Statin–Ezetimibe Combination to Reduce the Care Gap in Dyslipidemia Management in Patients With a High Risk of Atherosclerotic Disease
Aurora Mendelsohn
The American Journal of Cardiology, 2009
View PDFchevron_right
Statin use and fatal prostate cancer
Pamela Ohman-strickland, Alice David
Cancer, 2012
View PDFchevron_right
Statin Therapy in the Management of Diabetes Mellitus; How Relevant?
Olufemi Fasanmade
American Medical Journal, 2013
View PDFchevron_right
Randomized Dose-Response Study of Rosuvastatin in Japanese Patients With Hypercholesterolemia
ALI RAZA
Journal of Atherosclerosis and Thrombosis, 2003
View PDFchevron_right
Suboptimal use of statins at treatment initiation
Juha Hartikainen
European Journal of Clinical Pharmacology, 2011
View PDFchevron_right
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention
Vincenzo Pasceri
Journal of the American College of Cardiology, 2009
View PDFchevron_right
The poor design of clinical trials of statins in oncology may explain their failure – Lessons for drug repurposing
Alan Richardson
Cancer Treatment Reviews
View PDFchevron_right
Time-dependence of hypolipemic statin effects
Vladimir Miloradovic
The Medicus, 2005
View PDFchevron_right